Intelligencia

Intelligencia AI provides a suite of SaaS products, including Portfolio Optimizer and Dynamic Benchmarks, to assess the likelihood of success for drugs across multiple therapeutic areas. The platform utilizes explainable machine learning and curated biomedical data to help pharmaceutical and biotech companies identify technical and regulatory risks in their clinical development pipelines. These tools are used by portfolio strategy and decision analysis teams to optimize clinical trial design and evaluate competitive landscapes for acquisition and licensing.